| Primary |
| Product Used For Unknown Indication |
57.1% |
| Atrial Fibrillation |
14.3% |
| Cardiac Failure Chronic |
14.3% |
| Cardiac Failure Congestive |
14.3% |
|
| Vomiting |
28.6% |
| Suicide Attempt |
14.3% |
| Syncope |
14.3% |
| Toxicity To Various Agents |
14.3% |
| Venous Pressure Jugular |
14.3% |
| Ventricular Tachycardia |
14.3% |
|
| Secondary |
| Product Used For Unknown Indication |
45.1% |
| Myocardial Ischaemia |
13.2% |
| Atrial Fibrillation |
6.6% |
| Cardiac Failure |
6.6% |
| Toxicity To Various Agents |
6.6% |
| Arrhythmia |
3.3% |
| Depression |
3.3% |
| Urinary Tract Infection |
2.2% |
| Anticoagulant Therapy |
1.1% |
| Asthma |
1.1% |
| Cardioactive Drug Level Increased |
1.1% |
| Dyslipidaemia |
1.1% |
| Hypertension |
1.1% |
| Hypokalaemia |
1.1% |
| Immunodeficiency Common Variable |
1.1% |
| Initial Insomnia |
1.1% |
| Insomnia |
1.1% |
| Jaundice Cholestatic |
1.1% |
| Myelodysplastic Syndrome |
1.1% |
| Pain |
1.1% |
|
| Toxicity To Various Agents |
22.6% |
| Renal Failure Acute |
6.5% |
| Thrombocytopenia |
6.5% |
| Urticaria |
6.5% |
| Visual Impairment |
6.5% |
| Vomiting |
6.5% |
| Atrioventricular Block |
3.2% |
| Death |
3.2% |
| Exposure During Pregnancy |
3.2% |
| Heart Rate Increased |
3.2% |
| Malaise |
3.2% |
| Medication Error |
3.2% |
| Musculoskeletal Chest Pain |
3.2% |
| Palpitations |
3.2% |
| Respiratory Failure |
3.2% |
| Rhabdomyolysis |
3.2% |
| Suicide Attempt |
3.2% |
| Supraventricular Tachycardia |
3.2% |
| Tricuspid Valve Incompetence |
3.2% |
| Ventricular Flutter |
3.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
44.7% |
| Plasma Cell Myeloma |
10.1% |
| Chronic Myeloid Leukaemia |
5.0% |
| Pulmonary Arterial Hypertension |
5.0% |
| Depression |
3.9% |
| Hypertension |
3.9% |
| Osteoporosis |
3.9% |
| Cardiac Failure |
2.2% |
| Myelodysplastic Syndrome |
2.2% |
| Prostate Cancer Metastatic |
2.2% |
| Anxiety |
1.7% |
| Atrial Fibrillation |
1.7% |
| Cardiac Failure Congestive |
1.7% |
| Drug Use For Unknown Indication |
1.7% |
| Immunodeficiency Common Variable |
1.7% |
| Lower Respiratory Tract Infection |
1.7% |
| Mucopolysaccharidosis I |
1.7% |
| Parkinson's Disease |
1.7% |
| Status Epilepticus |
1.7% |
| Tuberous Sclerosis |
1.7% |
|
| Renal Failure Acute |
8.1% |
| Weight Decreased |
8.1% |
| Dyspnoea |
6.8% |
| International Normalised Ratio Increased |
6.8% |
| Nausea |
6.8% |
| Upper Gastrointestinal Haemorrhage |
6.8% |
| Pneumonia |
5.4% |
| Tachycardia |
5.4% |
| Unresponsive To Stimuli |
5.4% |
| Rash |
4.1% |
| Staphylococcal Infection |
4.1% |
| Urinary Tract Infection |
4.1% |
| Urosepsis |
4.1% |
| Varicose Vein |
4.1% |
| Vomiting |
4.1% |
| Weight Increased |
4.1% |
| White Blood Cell Count Increased |
4.1% |
| Musculoskeletal Chest Pain |
2.7% |
| Neutropenic Sepsis |
2.7% |
| Pancreatitis |
2.7% |
|
